K. Antoniou et al., DIFFERENTIAL-EFFECTS OF THE NEUROPEPTIDE GALANIN ON STRIATAL ACETYLCHOLINE-RELEASE IN ANESTHETIZED AND AWAKE RATS, British Journal of Pharmacology, 121(6), 1997, pp. 1180-1186
1 In the present study the mechanisms were examined by which the neuro
peptide galanin modulates the extracellular concentrations of striatal
acetylcholine (ACh) in enflurane anaesthetized and in freely moving m
ale rats by use of in vivo microdialysis and high performance liquid c
hromatography. 2 The perfusion of galanin through the microdialysis pr
obe (0.3 nmol mu l(-1), flow rate: 2 mu l min(-1)) caused a statistica
lly significant increase in the basal striatal ACh levels in anaesthet
ized but a decrease in awake animals. No significant effect was reveal
ed after a low dose (0.1 nmol mu l(-1). how rate: 2 mu l min(-1)) of g
alanin perfusion. Both the stimulating and inhibitory effects of galan
in on basal ACh release were reversible. 3 The muscarinic antagonist s
copolamine (0.1 mg kg(-1), subcutaneously (s.c.)) caused a significant
increase in ACh release in both anaesthetized and awake animals. 4 Th
e combination of galanin plus scopolamine attenuated the stimulant eff
ect on ACh release caused by scopolamine alone in awake animals. 5 The
putative galanin receptor antagonist M35 at 0.3 nmol mu l(-1) but not
at 0.1 nmol mu l(-1) caused a significant reduction (20%) in ACh rele
ase? supporting the view that M35 at higher concentrations behaves as
a partial agonist at the galanin receptor. When M35 (0.1 nmol mu l(-1)
) was co-infused with galanin (0.3 nmol mu l(-1)) the galanin-evoked d
ecrease in ACh release was completely blocked. 6 Taken together, these
results indicate that galanin affects basal ACh release via stimulati
on of galanin receptors within the striatum. The mechanism involved is
dependent on the anaesthesia procedure which may act via enhancement
of gamma-aminobutyric acid(A) (GABA(A)) mediated transmission within s
triatal and/or output neurones. In addition, anaesthesia may also decr
ease the activity of glutamatergic striatal afferents. The results wit
h M35 indicate that the role of galanin perfused in striatum is permis
sive in the normal rat. Furthermore. galanin is a potent inhibitory mo
dulator of basal ACh release also in the striatum, as recently was sho
wn in the ventral hippocampus in awake animals.